Research location

Bruderholz

Switzerland

Published trials24
Site observations24
Linked trials published24
Page1 / 1
Advertisement

Research activity in Bruderholz

Switzerland

CureCurrent currently publishes aggregate city-level research activity for this location: 24 trials and 24 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Bruderholz

24 linked trials · page 1 of 1
Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%NCT07020065 · 2026-04-10 · 1 site observation
RECRUITING
Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate CancerNCT03819101 · 2019-06-06 · 1 site observation
RECRUITING
Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)NCT03762122 · 2019-07-25 · 1 site observation
TERMINATED
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)NCT02366143 · 2015-03-31 · 1 site observation
COMPLETED
Global Non-interventional Heart Failure Disease RegistryNCT02595814 · 2014-07-23 · 1 site observation
TERMINATED
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)NCT01951625 · 2013-11-29 · 1 site observation
COMPLETED
A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes MellitusNCT01106651 · 2010-06-01 · 1 site observation
COMPLETED
Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).NCT01116219 · 2010-06-01 · 1 site observation
COMPLETED
Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)NCT01059188 · 2010-05-03 · 1 site observation
COMPLETED
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart FailureNCT00853658 · 2009-03-01 · 1 site observation
COMPLETED
Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung CancerNCT00768755 · 2009-01-01 · 1 site observation
COMPLETED
Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate CancerNCT00728663 · 2008-06-01 · 1 site observation
COMPLETED
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung CancerNCT00480025 · 2007-10-04 · 1 site observation
TERMINATED
Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)NCT00549757 · 2007-10-01 · 1 site observation
TERMINATED
A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®NCT00391027 · 2006-12-01 · 1 site observation
COMPLETED
Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir HypersensitivityNCT00340080 · 2006-04-01 · 1 site observation
COMPLETED
Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural MesotheliomaNCT00334594 · 2005-11-14 · 1 site observation
COMPLETED
Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast CancerNCT00238290 · 2005-05-01 · 1 site observation
COMPLETED
Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)NCT00163319 · 2004-11-01 · 1 site observation
COMPLETED
Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerNCT00217698 · 2003-11-01 · 1 site observation
COMPLETED
Fosamprenavir Expanded AccessNCT00240552 · 2003-07-01 · 1 site observation
COMPLETED
Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate CancerNCT00031889 · 2001-08-01 · 1 site observation
COMPLETED
Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC PatientsNCT00030771 · 2001-04-04 · 1 site observation
COMPLETED
TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.NCT00245739 · 1 site observation
APPROVED_FOR_MARKETING
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.